Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes
Author(s) -
Stosh Ozog,
Nina Timberlake,
Kip Hermann,
Olivia Garijo,
Kevin G. Haworth,
Guoli Shi,
Christopher M. Glinkerman,
Lauren E. Schefter,
Saritha S. D’Souza,
Elizabeth M. Simpson,
Gabriella Sghia-Hughes,
Raymond R. Carillo,
Dale L. Boger,
HansPeter Kiem,
Igor I. Slukvin,
Byoung Y. Ryu,
Brian P. Sorrentino,
Jennifer E. Adair,
Scott A. Snyder,
Alex A. Compton,
Bruce E. Torbett
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2019000040
Subject(s) - endosome , haematopoiesis , stem cell , gene delivery , microbiology and biotechnology , viral vector , biology , progenitor cell , resveratrol , hematopoietic stem cell , interferon , transmembrane protein , gene , genetic enhancement , cancer research , chemistry , virology , pharmacology , biochemistry , recombinant dna , receptor , intracellular
Key Points The cyclic resveratrol trimer caraphenol A safely enhances lentiviral vector gene delivery to hematopoietic stem and progenitor cells. Caraphenol A decreases interferon-induced transmembrane protein-mediated restriction in an endosomal trafficking-dependent manner.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom